Skip to Content

US panel backs COVID-19 boosters only for seniors, high-risk

By MATTHEW PERRONE and LAURAN NEERGAARD
Associated Press

WASHINGTON (AP) — An influential federal advisory panel has overwhelmingly rejected a plan to give Pfizer booster shots against COVID-19 to most Americans, but it endorsed the extra doses for those who are 65 or older or run a high risk of severe disease. The twin votes Friday represented a heavy blow to the Biden administration’s sweeping effort to shore up nearly all Americans’ protection amid the spread of the highly contagious delta variant. The decision was made by a committee of outside experts who advise the Food and Drug Administration. The White House called the action “an important step forward in providing better protection” from the virus.

Associated Press

Skip to content